Healthtech Startups

0 investors

0 investors

HeartSciences offers MyoVista Insights, a vendor-neutral platform that connects 12-lead ECG devices from over 30 manufacturers and lets healthcare providers run cleared AI-ECG algorithms, routing results into the patient chart via existing EHR workflows. It serves clinics and hospital systems in the cardiac diagnostics and health IT space.

0 investors

HeartFlow develops AI-powered software that analyzes coronary CT scans to diagnose and assess coronary artery disease by quantifying blood flow, plaque volume, and plaque composition for cardiologists and radiologists. The platform has been applied to over 600,000 patients and is used across more than 1,400 accounts in the United States.

0 investors

HearHero works to raise awareness of Sudden Cardiac Arrest and expand access to defibrillation, in partnership with cardiovascular care organizations. It operates in the cardiac health and emergency medical device space.

0 investors

Hedge Health provides a patient engagement and home exercise program platform for physical therapists and rehabilitation clinics to improve patient adherence and outcomes between in-office sessions. The app enables practitioners to create custom exercise programs, track patient progress, and reduce administrative burden.

0 investors

Heka Health builds mobile health solutions that use health sensors and mobile technology to connect individuals and their data with people and resources supporting their wellbeing, combining data analytics with human intervention to deliver personalized health insights. The company partners with organizations across the healthcare ecosystem to develop programs aimed at improving clinical outcomes and lowering cost of care.

0 investors

A digital asset treasury company that acquires and holds Solana tokens to maximize SOL per share through treasury management and staking activities, while maintaining a secondary focus on neurotechnology for neurological wellness.

0 investors

Helix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.

0 investors

0 investors

Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.

0 investors

Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.

0 investors

0 investors

HemoSonics develops FDA-cleared viscoelastic testing (VET) technology that provides real-time hemostasis data at the point of care for hospital teams managing bleeding in obstetric, trauma, and surgical settings. Its products support faster transfusion decisions and reduced blood product use in healthcare facilities.

0 investors

Hepanova is a clinical-stage biotech developing first-in-class oral small-molecule therapeutics for chronic liver diseases and inflammatory conditions, including MASH, liver fibrosis, and IBD. Its lead candidate, HPN-01, is an oral dual IKKα/IKKβ inhibitor that has completed a U.S. Phase 1 trial.

0 investors

Hepion Pharma is a pharmaceutical company with a therapeutic focus on hepatocellular carcinoma (liver cancer). This page is an investor presentations section with no substantive content available.

0 investors

0 investors

Hexamer Therapeutics develops a modular, room-temperature, peptide-based vaccine platform for therapeutic cancer and infectious disease vaccines, aiming to move quickly from disease target to active vaccine. It also licenses the platform to companies developing vaccines for animals such as swine, cattle, sheep, horses and companion animals.

0 investors

0 investors

0 investors

High Enroll works with clinical investigators and research teams to recruit participants for medical and scientific studies, aiming to improve research awareness, adoption, and engagement at research sites.

0 investors

0 investors

0 investors

0 investors